Drug Shortage Report for FRAXIPARINE FORTE
Report ID | 127472 |
Drug Identification Number | 02240114 |
Brand name | FRAXIPARINE FORTE |
Common or Proper name | Fraxiparine® Forte (nadroparin calcium injection (1.0 mL)) |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | NADROPARIN CALCIUM |
Strength(s) | 19000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10 PF Syringe |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-10-29 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-10-30 |
Company comments | n/a |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2020-10-30 | English | Compare |
v2 | 2020-10-29 | French | Compare |
v1 | 2020-10-29 | English | Compare |
Showing 1 to 3 of 3